Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies

Abstract Chemoradiotherapy (CRT) is an important treatment modality for specific gastrointestinal (GI) cancers, as it has been shown to improve clinical outcomes. Recent developments in the neoadjuvant setting such as wait-and-see strategies for rectal as well as for esophageal cancers have even proven that CRT might be an effective […]

View Original Source at Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies